1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Clinical Supply Management
  6.  » Excellence in Operating Multi-Center Clinical Trials

Excellence in Operating Multi-Center Clinical Trials

Please Note: This is a Chinese Language Recording

Summary: As the clinical development market evolves rapidly in China, an increasing number of domestic biotech sponsors are seeking to conduct clinical trials outside the APAC region, and conversely, a rising number of multi-national companies are initiating early phase clinical trials in China in parallel with other sponsor countries. To this end, there is a growing need for external support for clinical supply strategy development to help sponsors comply with clinical research regulations, navigate complex trial protocols and reduce the costs of running trials.

During this webinar, we are honored to have Dongmei Shi, Head of Global Clinical Development Center, Merck, China, Qian Huang, VP, Head of Clinical Operations, Reistone and Daniel Gao, General Manager of Catalent Pharma Solutions Clinical Supply Services, China to share their perspectives of multi-center clinical trial operations, and the importance of outsourcing partners in supporting study execution excellence. Lai Wang, Senior Vice President, Global Research, Clinical Operations, & Biometrics, and APAC Clinical Development, Beigene will join the panel and provide an additional perspective to the discussion and Q&A.

Click here to view the webinar